/Investor DB

Görlich Gruppe

Family office

Berlin · 3 people tracked

Find your way into Görlich Gruppe

Sign up to see every warm intro you have to Görlich Gruppe

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Görlich Gruppe team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Görlich Family Office operates with a multi-generational, disciplined yet risk-tolerant approach to wealth management, drawing on its experience with real estate holding companies to move into new sectors. It always co-invests with its clients, who are experienced in capital participations and able to bear risk. The firm sees biotechnology as a technology transforming medicine and acts as lead investor through its fund vehicle, giving semi-professional and professional investors access to this field. A current example is its lead investment via a special fund in 4TEEN4 Pharmaceuticals GmbH, developing a treatment for cardiogenic shock and an early-detection biomarker.

Invests inBiotechPropTechSector AgnosticBerlinEuropeGermany

Source: firm website, verified Aug 3, 2026.

HQ
Berlin, DE
Leads rounds
Leads
Instruments
Equity
Founded
1984
Tracked investments
2

Team · 3 people

from the firm's website

What they invest in

from 1 of 2 portfolio companies

Biotech ×1Healthtech ×1Medical Devices ×1

HQs:Germany×1

Investments · 2 tracked

founders shown can be your intro path
4TEEN4 Pharmaceuticals GmbH4teen4.dein

4TEEN4 develops monoclonal antibody therapeutics targeting shock and critical illness in patients.

BiotechHealthtechMedical DevicesHennigsdorf, DE

Dr. Andreas Bergmann(CEO)Dr. Joachim Struck(CRO)Dr. Karine Bourgeois(CSO)Prof. Mahir Karakas(CMO)inDr. Kilian von Seldeneck(CFO)Dr. Chris Springer(COO)in

Co-investorsBrandenburg Kapital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

4TEEN4

Portfolio news

latest coverage across their companies

Frequently asked questions

What sectors does Görlich Gruppe focus on?
Görlich Gruppe focuses on Biotech, PropTech, Sector Agnostic.
Where is Görlich Gruppe located?
Görlich Gruppe is headquartered in Berlin, DE.
Does Görlich Gruppe lead rounds?
Yes, Görlich Gruppe leads investment rounds.

Similar investors

Featured in lists